Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response.
The metabolic events associated with maintaining redox homeostasis in Mycobacterium tuberculosis (Mtb) during infection are poorly understood. Here, we discovered a novel redox switching mechanism by which Mtb WhiB3 under defined oxidizing and reducing conditions differentially modulates the assimilation of propionate into the complex virulence polyketides polyacyltrehaloses (PAT), sulfolipids (SL-1), phthiocerol dimycocerosates (PDIM), and the storage lipid triacylglycerol (TAG) that is under control of the DosR/S/T dormancy system. We developed an in vivo radio-labeling technique and demonstrated for the first time the lipid profile changes of Mtb residing in macrophages, and identified WhiB3 as a physiological regulator of virulence lipid anabolism. Importantly, MtbDeltawhiB3 shows enhanced growth on medium containing toxic levels of propionate, thereby implicating WhiB3 in detoxifying excess propionate. Strikingly, the accumulation of reducing equivalents in MtbDeltawhiB3 isolated from macrophages suggests that WhiB3 maintains intracellular redox homeostasis upon infection, and that intrabacterial lipid anabolism functions as a reductant sink. MtbDeltawhiB3 infected macrophages produce higher levels of pro- and anti-inflammatory cytokines, indicating that WhiB3-mediated regulation of lipids is required for controlling the innate immune response. Lastly, WhiB3 binds to pks2 and pks3 promoter DNA independent of the presence or redox state of its [4Fe-4S] cluster. Interestingly, reduction of the apo-WhiB3 Cys thiols abolished DNA binding, whereas oxidation stimulated DNA binding. These results confirmed that WhiB3 DNA binding is reversibly regulated by a thiol-disulfide redox switch. These results introduce a new paradigmatic mechanism that describes how WhiB3 facilitates metabolic switching to fatty acids by regulating Mtb lipid anabolism in response to oxido-reductive stress associated with infection, for maintaining redox balance. The link between the WhiB3 virulence pathway and DosR/S/T signaling pathway conceptually advances our understanding of the metabolic adaptation and redox-based signaling events exploited by Mtb to maintain long-term persistence.
Singh
Amit
A
Department of Microbiology, Centers for Free Radical Biology, AIDS Research, and Emerging Infections and Emergency Preparedness, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Crossman
David K
DK
Mai
Deborah
D
Guidry
Loni
L
Voskuil
Martin I
MI
Renfrow
Matthew B
MB
Steyn
Adrie J C
AJ
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology / Q000378:metabolism; D001426:Bacterial Proteins / Q000276:immunology / Q000378:metabolism*; D002460:Cell Line; D002473:Cell Wall / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D006706:Homeostasis; D054884:Host-Pathogen Interactions; D050356:Lipid Metabolism / Q000502:physiology*; D008055:Lipids / Q000032:analysis / Q000096:biosynthesis; D008264:Macrophages / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000378:metabolism* / Q000472:pathogenicity; D010084:Oxidation-Reduction; D011422:Propionates / Q000378:metabolism; D014376:Tuberculosis / Q000378:metabolism*; D014774:Virulence
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D008055:Lipids; D011422:Propionates
J Biol Chem. 2008 Jul 11;283(28):19329-41
18490451
Cell. 2002 May 3;109(3):383-96
12015987
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11562-7
17609386
Cell Host Microbe. 2007 Nov 15;2(5):352-64
18005756
J Pharm Biomed Anal. 2004 Mar 10;34(5):1091-8
15019043
J Bacteriol. 2007 Apr;189(7):2583-9
17237171
J Bacteriol. 2007 Sep;189(17):6372-81
17526704
J Biol Chem. 2001 Jun 8;276(23):19845-54
11279114
Mol Microbiol. 2006 Apr;60(2):312-30
16573683
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2453-7
2538841
Microbiology (Reading). 2007 Dec;153(Pt 12):3973-3982
18048912
J Biol Chem. 2007 Nov 2;282(44):31909-19
17827500
J Immunol. 1999 Jun 1;162(11):6740-6
10352293
Tuberculosis (Edinb). 2004;84(6):375-85
15525561
J Biol Chem. 2008 Jun 27;283(26):18032-9
18400743
Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6630-4
7604045
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3147-52
11880648
J Biol Chem. 2004 Sep 17;279(38):40174-84
15247240
J Bacteriol. 1998 Feb;180(4):801-8
9473032
Science. 2008 Mar 21;319(5870):1672-6
18356528
EMBO J. 1994 Jan 15;13(2):453-61
7508861
J Bacteriol. 1956 Aug;72(2):132-41
13366889
J Mol Biol. 2007 Jun 22;369(5):1307-17
17498742
Appl Microbiol Biotechnol. 2002 Dec;60(4):367-76
12466875
Cell Microbiol. 2004 Mar;6(3):277-87
14764111
Nature. 2004 Sep 2;431(7004):84-7
15343336
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8554-9
10880571
Tuberculosis (Edinb). 2007 Mar;87(2):78-86
17030019
Biochimie. 2004 Nov;86(11):807-15
15589690
Mol Microbiol. 2006 Jun;60(5):1109-22
16689789
Biochem Biophys Res Commun. 2005 Nov 25;337(3):757-64
16212936
Mol Microbiol. 2007 Mar;63(5):1414-31
17302817
Infect Immun. 2006 Nov;74(11):6449-57
16923787
J Biol Chem. 1996 Dec 27;271(52):33173-5
8969171
J Lipid Res. 2008 Feb;49(2):282-94
17965457
Biochim Biophys Acta. 2008 Nov;1780(11):1201-16
18252205
Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6625-9
7604044
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11168-72
9326580
JAMA. 1999 Aug 18;282(7):677-86
10517722
Microbiology (Reading). 2003 Jul;149(Pt 7):1837-1847
12855735
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12200-5
16103351
J Bacteriol. 2004 Aug;186(15):5017-30
15262939
Nat Rev Microbiol. 2004 Dec;2(12):954-66
15550941
PLoS Med. 2008 Apr 1;5(4):e75
18384229
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5133-8
17360366
Anal Bioanal Chem. 2007 Nov;389(5):1397-407
17712550